Brandinium

Trademark search for:

PROTRITAC

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2022-08-22 — Application filed
  • 2022-08-25 — Application filed
  • 2022-09-11 — Application filed
  • 2023-06-08 — Assigned to examiner
  • 2023-06-12 — Priority action written
  • 2023-06-12 — Priority action e-mailed
  • 2023-06-12 — Notification of priority action e-mailed
  • 2023-07-06 — Office action issued
  • 2023-07-06 — Correspondence received in law office
  • 2023-07-07 — Teas/email correspondence entered
  • 2023-07-08 — Approved for pub - principal register
  • 2023-07-26 — Notification of notice of publication e-mailed
  • 2023-08-15 — Published for opposition
  • 2023-08-15 — Official gazette publication confirmation e-mailed
  • 2023-10-10 — Noa e-mailed - sou required from applicant
  • 2024-04-01 — Teas change of owner address received
  • 2024-04-01 — Applicant/correspondence changes (non-responsive) entered
  • 2024-04-01 — Teas revoke/app/change addr of atty/dom rep received
  • 2024-04-01 — Attorney/dom.rep.revoked and/or appointed
  • 2024-04-01 — Teas change of correspondence received
  • 2024-04-02 — Sou teas extension received
  • 2024-04-02 — Sou extension 1 filed
  • 2024-04-02 — Sou extension 1 granted
  • 2024-04-03 — Notice of approval of extension request e-mailed
  • 2024-09-12 — Sou teas extension received
  • 2024-09-12 — Sou extension 2 filed
  • 2024-09-12 — Sou extension 2 granted
  • 2024-09-12 — Notice of approval of extension request e-mailed
  • 2025-04-02 — Sou teas extension received
  • 2025-04-02 — Sou extension 3 filed
  • 2025-04-03 — Sou extension 3 granted
  • 2025-04-03 — Notice of approval of extension request e-mailed
  • 2025-11-10 — Application abandoned
  • 2025-11-10 — Application abandoned
  • 2025-11-10 — Final status recorded

Owner Information

Harpoon Therapeutics, Inc.
South San Francisco , CA
Harpoon Therapeutics, Inc.
South San Francisco , CA

Correspondent

Lisa M. Dellamura Merck & Co., Inc.
126 East Lincoln Avenue
Rahway, NJ 07065
United States

Filing Details

Filing Date:
2022-08-22
Status Date:
2025-11-10
Category:
Pharmaceuticals
Filing Year:
2018

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.